AAAAAA

   
Results: 1-25 | 26-34
Results: 1-25/34
AMORPHOUS POLYMORPHISM IN ICE INVESTIGATED BY INELASTIC NEUTRON-SCATTERING
Authors: SCHOBER H KOZA M TOLLE A FUJARA F ANGELL CA BOHMER R
Citation: H. Schober et al., AMORPHOUS POLYMORPHISM IN ICE INVESTIGATED BY INELASTIC NEUTRON-SCATTERING, Physica. B, Condensed matter, 241, 1997, pp. 897-902
CLINICAL AND LABORATORY VALIDATION OF VARIOUS TESTS FOR THE DIAGNOSISOF HEPARIN-INDUCED THROMBOCYTOPENIA (HIT)
Authors: FAREED J WALENGA JM JESKE W KOZA M HOPPENSTEADT D RAIBLE M MESSMORE HL
Citation: J. Fareed et al., CLINICAL AND LABORATORY VALIDATION OF VARIOUS TESTS FOR THE DIAGNOSISOF HEPARIN-INDUCED THROMBOCYTOPENIA (HIT), The FASEB journal, 10(3), 1996, pp. 2553-2553
MULTIWAVELENGTH DFB LASER ARRAY TRANSMITTERS FOR ONTC RECONFIGURABLE OPTICAL NETWORK TESTBED
Authors: LEE TP ZAH CE BHAT R YOUNG WC PATHAK B FAVIRE F LIN PSD ANDREADAKIS NC CANEAU C RAHJEL AW KOZA M GAMELIN JK CURTIS L MAHONEY DD LEPORE A
Citation: Tp. Lee et al., MULTIWAVELENGTH DFB LASER ARRAY TRANSMITTERS FOR ONTC RECONFIGURABLE OPTICAL NETWORK TESTBED, Journal of lightwave technology, 14(6), 1996, pp. 967-976
FLOW CYTOMETRIC EVALUATION OF THE EFFECT OF VARIOUS THROMBIN INHIBITORS ON PLATELET ACTIVATION IN WHOLE-BLOOD
Authors: KAISER B KOZA M WALENGA JM FAREED J
Citation: B. Kaiser et al., FLOW CYTOMETRIC EVALUATION OF THE EFFECT OF VARIOUS THROMBIN INHIBITORS ON PLATELET ACTIVATION IN WHOLE-BLOOD, Thrombosis research, 82(3), 1996, pp. 257-263
NEWER ANTITHROMBOTIC AND ANTICOAGULANT DRUGS FOR INTERVENTIONAL RADIOLOGIC PROCEDURES
Authors: IQBAL O FAREED J HOPPENSTEADT D WALENGA JM KOZA M MONCADA R
Citation: O. Iqbal et al., NEWER ANTITHROMBOTIC AND ANTICOAGULANT DRUGS FOR INTERVENTIONAL RADIOLOGIC PROCEDURES, Radiology, 201, 1996, pp. 265-265
IONIC CONTRAST-MEDIA INHIBIT THROMBIN RECEPTOR-MEDIATED ACTIVATION OFPLATELETS - STUDIES WITH [001A] THROMBIN AND THROMBIN RECEPTOR-ACTIVATING PEPTIDE
Authors: FAREED J IQBAL O HOPPENSTEADT D KOZA M MONCADA R
Citation: J. Fareed et al., IONIC CONTRAST-MEDIA INHIBIT THROMBIN RECEPTOR-MEDIATED ACTIVATION OFPLATELETS - STUDIES WITH [001A] THROMBIN AND THROMBIN RECEPTOR-ACTIVATING PEPTIDE, Radiology, 201, 1996, pp. 1009-1009
GLYCOPROTEIN IIB IIIA INHIBITORS CAN PREVENT HEPARIN MEDIATED PLATELET ACTIVATION IN HEPARIN-INDUCED THROMBOCYTOPENIA/
Authors: FAREED J YANG LH HOPPENSTEADT D KOZA M WALENGA JM WELZEL D
Citation: J. Fareed et al., GLYCOPROTEIN IIB IIIA INHIBITORS CAN PREVENT HEPARIN MEDIATED PLATELET ACTIVATION IN HEPARIN-INDUCED THROMBOCYTOPENIA/, Circulation, 94(8), 1996, pp. 1333-1333
CLINICAL AND LABORATORY VALIDATION OF VARIOUS TESTS FOR THE DIAGNOSISOF HEPARIN-INDUCED THROMBOCYTOPENIA
Authors: HOPPENSTEADT D BLAKEMORE C RAIBLE M WALENGA JM KOZA M FAREED J
Citation: D. Hoppensteadt et al., CLINICAL AND LABORATORY VALIDATION OF VARIOUS TESTS FOR THE DIAGNOSISOF HEPARIN-INDUCED THROMBOCYTOPENIA, Circulation, 94(8), 1996, pp. 4348-4348
DEFIBROTIDE MEDIATED INHIBITION OF SEROTONIN AND THROMBOXANE INDUCED CONTRACTION OF DOG FEMORAL AND PULMONARY AORTIC STRIP
Authors: YANG LH PIFARRE R KOZA M IQBAL O NAZZARI M
Citation: Lh. Yang et al., DEFIBROTIDE MEDIATED INHIBITION OF SEROTONIN AND THROMBOXANE INDUCED CONTRACTION OF DOG FEMORAL AND PULMONARY AORTIC STRIP, Thrombosis and haemostasis, 73(6), 1995, pp. 902-902
THE ROLE OF TISSUE FACTOR PATHWAY INHIBITOR (TFPI) IN THE MEDIATION OF THE ANTITHROMBOTIC ACTIONS OF HEPARIN AND LOW-MOLECULAR-WEIGHT HEPARIN
Authors: HOPPENSTEADT D KOZA M WALENGA JM LEYA F PIFARRE R BERMES EW
Citation: D. Hoppensteadt et al., THE ROLE OF TISSUE FACTOR PATHWAY INHIBITOR (TFPI) IN THE MEDIATION OF THE ANTITHROMBOTIC ACTIONS OF HEPARIN AND LOW-MOLECULAR-WEIGHT HEPARIN, Thrombosis and haemostasis, 73(6), 1995, pp. 944-944
MODULATION OF R-TISSUE FACTOR AND ARACHIDONIC-ACID INDUCED PLATELET ACTIVATION IN WHOLE-BLOOD BY VARIOUS THROMBIN INHIBITORS
Authors: KAISER B KOZA M SHANKEY TV WALENGA JM FAREED J
Citation: B. Kaiser et al., MODULATION OF R-TISSUE FACTOR AND ARACHIDONIC-ACID INDUCED PLATELET ACTIVATION IN WHOLE-BLOOD BY VARIOUS THROMBIN INHIBITORS, Thrombosis and haemostasis, 73(6), 1995, pp. 1308-1308
PROCOAGULANT AND ANTICOAGULANT EFFECTS OF INTRAVASCULAR CONTRAST-MEDIA AS ASSESSED BY THROMBOELASTOGRAPHY
Authors: IQBAL O JESKE W HOPPENSTEADT D KOZA M WALENGA JM FAREED J MONCADA R
Citation: O. Iqbal et al., PROCOAGULANT AND ANTICOAGULANT EFFECTS OF INTRAVASCULAR CONTRAST-MEDIA AS ASSESSED BY THROMBOELASTOGRAPHY, Seminars in thrombosis and hemostasis, 21, 1995, pp. 86-90
TISSUE FACTOR (TF) AND HEPARIN-RELEASABLE TISSUE FACTOR PATHWAY INHIBITOR (TFPI) DURING INTERVENTIONAL CARDIOVASCULAR PROCEDURES
Authors: WALENGA JM HOPPENSTEADT D KOZA M FAREED J PIFARRE R BERMES EW
Citation: Jm. Walenga et al., TISSUE FACTOR (TF) AND HEPARIN-RELEASABLE TISSUE FACTOR PATHWAY INHIBITOR (TFPI) DURING INTERVENTIONAL CARDIOVASCULAR PROCEDURES, Clinical chemistry, 41(6), 1995, pp. 55-56
HEPARIN-INDUCED THROMBOCYTOPENIC POTENTIAL OF UNFRACTIONATED HEPARIN AND LOW-MOLECULAR-WEIGHT HEPARINS AS MEASURED BY A FLOW CYTOMETRIC METHOD
Authors: KOZA M WALENGA JM SHANKEY TV HOPPENSTEADT D FAREED J LONCHYNA V PIFARRE R BERMES EW
Citation: M. Koza et al., HEPARIN-INDUCED THROMBOCYTOPENIC POTENTIAL OF UNFRACTIONATED HEPARIN AND LOW-MOLECULAR-WEIGHT HEPARINS AS MEASURED BY A FLOW CYTOMETRIC METHOD, Clinical chemistry, 41(6), 1995, pp. 99-99
CYTOKINE THERAPY IN MAJOR INJURY - INFECTION AND HEMOSTASIS ISSUES
Authors: HOPPENSTEADT D DRIES D WALENGA JM KOZA M FAREED J BERMES EW
Citation: D. Hoppensteadt et al., CYTOKINE THERAPY IN MAJOR INJURY - INFECTION AND HEMOSTASIS ISSUES, Clinical chemistry, 41(6), 1995, pp. 101-101
FLOW CYTOMETRIC STUDIES ON THE INHIBITION OF AGONIST-INDUCED PLATELETACTIVATION IN WHOLE-BLOOD BY ACTIVATED PROTEIN-C
Authors: KAISER B KOZA M WALENGA JM FAREED J
Citation: B. Kaiser et al., FLOW CYTOMETRIC STUDIES ON THE INHIBITION OF AGONIST-INDUCED PLATELETACTIVATION IN WHOLE-BLOOD BY ACTIVATED PROTEIN-C, Blood, 86(10), 1995, pp. 3585-3585
EFFICACY OF NEWER ANTICOAGULANTS AS MEASURED IN A RAT MODEL OF CRUSH-AVULSION ANASTOMOSIS MODEL
Authors: FU KD IZQUIERDO R IQBAL O KOZA M FAREED J
Citation: Kd. Fu et al., EFFICACY OF NEWER ANTICOAGULANTS AS MEASURED IN A RAT MODEL OF CRUSH-AVULSION ANASTOMOSIS MODEL, The FASEB journal, 8(5), 1994, pp. 10000901-10000901
DOSAGE EQUIVALENCE FOR LOW-MOLECULAR-WEIGHT HEPARINS FOR SURGICAL ANTICOAGULATION
Authors: ASSELMEIER S OVSEPIAN A KOZA M IQBAL I FAREED J
Citation: S. Asselmeier et al., DOSAGE EQUIVALENCE FOR LOW-MOLECULAR-WEIGHT HEPARINS FOR SURGICAL ANTICOAGULATION, The FASEB journal, 8(4), 1994, pp. 10000098-10000098
UTILITY OF THE HEPTEST AND A CHROMOGENIC SUBSTRATE METHOD TO ASSESS ANTICOAGULATION IN PATIENTS REFRACTORY TO HEPARINIZATION BY THE ACTIVATED PARTIAL THROMBOPLASTIN TIME METHOD
Authors: MESSMORE HL KOZA M FARID S WEHRMACHER WH
Citation: Hl. Messmore et al., UTILITY OF THE HEPTEST AND A CHROMOGENIC SUBSTRATE METHOD TO ASSESS ANTICOAGULATION IN PATIENTS REFRACTORY TO HEPARINIZATION BY THE ACTIVATED PARTIAL THROMBOPLASTIN TIME METHOD, Seminars in thrombosis and hemostasis, 20(4), 1994, pp. 351-352
HEPARIN-RELEASABLE TISSUE FACTOR PATHWAY INHIBITOR DURING INTERVENTIONAL CARDIOVASCULAR PROCEDURES
Authors: BICK RL FAREED J WALENGA JW KOZA M HOPPENSTEADT D LEVA F PIFARRE R
Citation: Rl. Bick et al., HEPARIN-RELEASABLE TISSUE FACTOR PATHWAY INHIBITOR DURING INTERVENTIONAL CARDIOVASCULAR PROCEDURES, Blood, 84(10), 1994, pp. 10000081-10000081
EFFECT OF RECOMBINANT HIRUDIN AND ITS POLYETHYLENE-GLYCOL COUPLED DERIVATIVE (PEG-HIRUDIN) ON TISSUE FACTOR ACTIVATION OF HUMAN PLATELETS AS STUDIED BY FLOW CYTOMETRIC ANALYSIS
Authors: NORLUND M KOZA M ESCHENFELDER V FAREED J
Citation: M. Norlund et al., EFFECT OF RECOMBINANT HIRUDIN AND ITS POLYETHYLENE-GLYCOL COUPLED DERIVATIVE (PEG-HIRUDIN) ON TISSUE FACTOR ACTIVATION OF HUMAN PLATELETS AS STUDIED BY FLOW CYTOMETRIC ANALYSIS, Blood, 84(10), 1994, pp. 10000689-10000689
A PROPOSAL FOR AN UPDATED SYSTEMIC WORK-UP FOR PATIENTS WITH ORAL ANTICOAGULATION RESISTANCE
Authors: WROBLEWSKI D HOPPENSTEADT D MORAN S KOZA M FAREED J
Citation: D. Wroblewski et al., A PROPOSAL FOR AN UPDATED SYSTEMIC WORK-UP FOR PATIENTS WITH ORAL ANTICOAGULATION RESISTANCE, Thrombosis and haemostasis, 69(6), 1993, pp. 676-676
LIMITED ROLE OF THROMBIN IN PLATELET ACTIVATION AS MEASURED BY FLOW-CYTOMETRY USING CD-62 MONOCLONAL-ANTIBODY AS GMP-140 EXPRESSION MARKERS
Authors: JATO JL KOZA M WALENGA JM BEISSINGER R SHANKEY V FAREED J POTOCKI D
Citation: Jl. Jato et al., LIMITED ROLE OF THROMBIN IN PLATELET ACTIVATION AS MEASURED BY FLOW-CYTOMETRY USING CD-62 MONOCLONAL-ANTIBODY AS GMP-140 EXPRESSION MARKERS, Thrombosis and haemostasis, 69(6), 1993, pp. 705-705
WHOLE-BLOOD HEPTEST H(TM) MAY BE BETTER THAN THE WHOLE-BLOOD ACTIVATED CLOTTING TIME TO MONITOR ANTICOAGULATION IN PATIENTS UNDERGOING PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY OF THE CORONARY-ARTERIES
Authors: MESSMORE HL JOHNSON SA SCANLON PJ LEYA F MCKIERNAN TL FISHER SA FARID S KOZA M HALLE AA
Citation: Hl. Messmore et al., WHOLE-BLOOD HEPTEST H(TM) MAY BE BETTER THAN THE WHOLE-BLOOD ACTIVATED CLOTTING TIME TO MONITOR ANTICOAGULATION IN PATIENTS UNDERGOING PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY OF THE CORONARY-ARTERIES, Thrombosis and haemostasis, 69(6), 1993, pp. 865-865
COMPARATIVE PHARMACOLOGICAL STUDIES ON A NEW LOW-MOLECULAR-WEIGHT HEPARIN (MERCKLE LMWH) AND ENOXAPARIN (R)
Authors: MALINOWSKA K KOZA M IQBAL O HOPPENSTEADT D EMMERT HK FAREED J
Citation: K. Malinowska et al., COMPARATIVE PHARMACOLOGICAL STUDIES ON A NEW LOW-MOLECULAR-WEIGHT HEPARIN (MERCKLE LMWH) AND ENOXAPARIN (R), Thrombosis and haemostasis, 69(6), 1993, pp. 891-891
Risultati: 1-25 | 26-34